Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia

The use of oncolytic viruses has emerged as a promising therapeutic approach due to the features of these viruses, which selectively replicate and destroy tumor cells while sparing normal cells. Although numerous oncolytic viruses have been developed for testing in solid tumors, only a few have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zixuan, Liu, Wenmo, Wang, Lizheng, Gao, Peng, Li, Zhe, Wu, Jiaxin, Zhang, Haihong, Wu, Hui, Kong, Wei, Yu, Bin, Yu, Xianghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181830/
https://www.ncbi.nlm.nih.gov/pubmed/32327638
http://dx.doi.org/10.1038/s41392-020-0135-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181830/
https://www.ncbi.nlm.nih.gov/pubmed/32327638
http://dx.doi.org/10.1038/s41392-020-0135-9

Ejemplares similares